Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin plus vitamin C in septic shock
IRCT20190215042716N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of atorvastatin and ascorbic acid in septic shock (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Mortality rate. Started Dec 2022; status: completed.
02
Drugs
atorvastatinascorbic acid
03
Conditions
septic shock
Beyond the preview
Go deeper on IRCT20190215042716N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190215042716N3.